Benjamin Lewis, MD

Journal Article

1. Garland, Eric L; Lewis, Benjamin R; Thielking, P; Odette, Madeleine; Pfeffer, H; Shen, (2026). Ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder: a randomized controlled trial. Nature Mental Health,
2. Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland E (2025). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. PLoS medicine, 22(9), e1004519.
3. Kious BM, Lewis BR, Kim SY (2023). Epistemic injustice and the psychiatrist. Psychological medicine, 53(1), 1-5.
4. Lewis BR, Hendrick J, Byrne K, Garland E, Thielking P, Beck (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. Journal of psychedelic studies, https://doi.org/10.1556/2054.2022.00222.
5. Byrne K, Lindsay S, Baker N, Schmutz C, Lewis (2023). In Naturalistic Psychedelic Use, Group Use is Common and Acceptable. Journal of psychedelic studies, https://doi.org/10.1556/2054.2023.00261.
6. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. Journal of pain and symptom management, 66(3), 258-269.
7. Kious BM, Lewis BR, Kim SY (2023). 'What does epistemic injustice add? A response to Grim and Aftab'. Psychological medicine, 53(12), 5879-5881.
8. Kious BM, Schwartz Z, Lewis B (2022). Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers. Journal of psychopharmacology (Oxford, England), 37(1), 45-48.
9. Lewis BR, Byrne (2021). Update on Psychedelic Therapies for Mental Health. Clinical and Forensic Toxicology News, 1-5.
10. Case GA, Pippitt KA, Lewis B (2018). Shame. Perspectives on medical education, 7(Suppl 1), 12-15.
11. Benjamin R. Lewis MD, Matthew J Reid PhD, Andrew Novick MD, Kevin Byrne MD, Mark J. Niciu MD, PhD, Gregory A. Fonzo PhD, Thomas Meyer PhD, David Feifel MD, PhD, Rifaat El-Mallakh MD, Jair Soares MD, PhD, Trisha Suppes MD, PhD, Frederick S. Barrett Ph Challenges with Clinical Trial Participants in Studies with Classical Psychedelics: A Position Statement from the National Network of Depression Centers’ Task Group on Psychedelics and Related Compounds. . Journal of Psychopharmacology,
12. Lewis BR, Garland E Is Ketamine Really a Dissociative? Effects of Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement on Interoceptive Awareness in Patients with Opioid Use Disorder Treated with Buprenorphine. under review,
13. Lewis BR, Garland E, Schwartz Z, Xin Y, Byrne K, Kious What’s Good for the Goose? Study Participant Perceptions as to the Relevance of Therapist and Study Team Prior Personal Psychedelic Experience. under review,

Review

1. Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett F (2025). Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds. EClinicalMedicine, 89, 103517.
2. Lewis BR, Byrne (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. Focus (American Psychiatric Publishing), 21(3), 247-256.
3. Lewis BR, Byrne (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials?. Journal of psychedelic studies, 5(2), 65-68.

Book Chapter

1. Lewis BR, Kious B (2015). The organic-functional distinction.

Conference Proceedings

1. Lewis (2011). Taking the Psychiatric Stance: Mental Illness in Dennettian Context. AAPP Bulletin, pending publication in Oxford U Press compilation of essays on philosophical issues in evidence-based psychiatry.

Commentary

1. Lewis BR, Byrne K, Beck (2023). Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer). Journal of anesthesiology and pain therapy, 4(3), 1-3.
2. Lewis B (2021). Some aspects of containment matter. Philosophy, psychiatry, & psychology, 28(3), 223-225.
3. Lewis B (2015). On the Overvaluation of Misvaluation. Philosophy, psychiatry, & psychology, 22(1),
4. Lewis B (2015). "The Drugs Didn't Mix: On the Overvaluation of Misvaluation". Philosophy, psychiatry, & psychology, 22(1), 41-43.

Editorial

1. Loughlin M, Bluhm R, Fuller J, Buetow S, Borgerson K, Lewis BR, Kious B (2015). Diseases, patients and the epistemology of practice: mapping the borders of health, medicine and care. Journal of evaluation in clinical practice, 21(3), 357-64.

Letter

1. Kious BM, Lewis BR, Kim SY (2023). What does epistemic injustice add? A response to Grim and Aftab . Psychological medicine, 53(12), 5879-5881.
2. Kious BM, Lewis B (2019). Classifying psychiatric disorders as communicable diseases. The lancet. Psychiatry, 6(1), 13-14.

News

• New Ketamine-Assisted Psychotherapy Clinic Opens at Huntsman Mental Health Institute (HMHI)
• Returning to Campus? Don't Forget About Your Mental Health 
• Fast Facts About Ketamine for Depression
• Mushrooms for Depression? Psilocybin is Showing Promising Results
• Patient with inoperable cancer finds peace through ketamine
• Ketamine-Assisted Psychotherapy Clinic Aims to Bring Relief to People Facing Existential Distress
• Clinical investigators receive award for research innovation
• Brains on brains: Exciting new advances from the best minds in research
• Psilocybin + Mindfulness Shows Promise for Healthcare Worker Depression: Report
• Utah authorizes state-funded psychedelic research for veterans with PTSD